Cargando…

Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study

OBJECTIVE: To determine characteristics associated with COVID-19 vaccine coverage among individuals aged 50 years and above in England since the beginning of the programme. DESIGN: Observational cross-sectional study assessed by logistic regression and mean prevalence margins. SETTING: COVID-19 vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tessier, Elise, Rai, Yuma, Clarke, Eleanor, Lakhani, Anissa, Tsang, Camille, Makwana, Ashley, Heard, Heather, Rickeard, Tim, Lakhani, Shreya, Roy, Partho, Edelstein, Michael, Ramsay, Mary, Lopez-Bernal, Jamie, White, Joanne, Andrews, Nick, Campbell, Colin N J, Stowe, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889452/
https://www.ncbi.nlm.nih.gov/pubmed/35232787
http://dx.doi.org/10.1136/bmjopen-2021-055278
_version_ 1784661404232450048
author Tessier, Elise
Rai, Yuma
Clarke, Eleanor
Lakhani, Anissa
Tsang, Camille
Makwana, Ashley
Heard, Heather
Rickeard, Tim
Lakhani, Shreya
Roy, Partho
Edelstein, Michael
Ramsay, Mary
Lopez-Bernal, Jamie
White, Joanne
Andrews, Nick
Campbell, Colin N J
Stowe, Julia
author_facet Tessier, Elise
Rai, Yuma
Clarke, Eleanor
Lakhani, Anissa
Tsang, Camille
Makwana, Ashley
Heard, Heather
Rickeard, Tim
Lakhani, Shreya
Roy, Partho
Edelstein, Michael
Ramsay, Mary
Lopez-Bernal, Jamie
White, Joanne
Andrews, Nick
Campbell, Colin N J
Stowe, Julia
author_sort Tessier, Elise
collection PubMed
description OBJECTIVE: To determine characteristics associated with COVID-19 vaccine coverage among individuals aged 50 years and above in England since the beginning of the programme. DESIGN: Observational cross-sectional study assessed by logistic regression and mean prevalence margins. SETTING: COVID-19 vaccinations delivered in England from 8 December 2020 to 17 May 2021. PARTICIPANTS: 30 624 257/61 967 781 (49.4%) and 17 360 045/61 967 781 (28.1%) individuals in England were recorded as vaccinated in the National Immunisation Management System with a first dose and a second dose of a COVID-19 vaccine, respectively. INTERVENTIONS: Vaccination status with COVID-19 vaccinations. MAIN OUTCOME MEASURES: Proportion, adjusted ORs and mean prevalence margins for individuals not vaccinated with dose 1 among those aged 50–69 years and dose 1 and 2 among those aged 70 years and above. RESULTS: Of individuals aged 50 years and above, black/African/Caribbean ethnic group was the least likely of all ethnic groups to be vaccinated with dose 1 of the COVID-19 vaccine. However, of those aged 70 years and above, the odds of not having dose 2 was 5.53 (95% CI 5.42 to 5.63) and 5.36 (95% CI 5.29 to 5.43) greater among Pakistani and black/African/Caribbean compared with white British ethnicity, respectively. The odds of not receiving dose 2 was 1.18 (95% CI 1.16 to 1.20) higher among individuals who lived in a care home compared with those who did not. This was the opposite to that observed for dose 1, where the odds of being unvaccinated was significantly higher among those not living in a care home (0.89 (95% CI 0.87 to 0.91)). CONCLUSIONS: We found that there are characteristics associated with low COVID-19 vaccine coverage. Inequalities, such as ethnicity are a major contributor to suboptimal coverage and tailored interventions are required to improve coverage and protect the population from SARS-CoV-2.
format Online
Article
Text
id pubmed-8889452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88894522022-03-02 Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study Tessier, Elise Rai, Yuma Clarke, Eleanor Lakhani, Anissa Tsang, Camille Makwana, Ashley Heard, Heather Rickeard, Tim Lakhani, Shreya Roy, Partho Edelstein, Michael Ramsay, Mary Lopez-Bernal, Jamie White, Joanne Andrews, Nick Campbell, Colin N J Stowe, Julia BMJ Open Epidemiology OBJECTIVE: To determine characteristics associated with COVID-19 vaccine coverage among individuals aged 50 years and above in England since the beginning of the programme. DESIGN: Observational cross-sectional study assessed by logistic regression and mean prevalence margins. SETTING: COVID-19 vaccinations delivered in England from 8 December 2020 to 17 May 2021. PARTICIPANTS: 30 624 257/61 967 781 (49.4%) and 17 360 045/61 967 781 (28.1%) individuals in England were recorded as vaccinated in the National Immunisation Management System with a first dose and a second dose of a COVID-19 vaccine, respectively. INTERVENTIONS: Vaccination status with COVID-19 vaccinations. MAIN OUTCOME MEASURES: Proportion, adjusted ORs and mean prevalence margins for individuals not vaccinated with dose 1 among those aged 50–69 years and dose 1 and 2 among those aged 70 years and above. RESULTS: Of individuals aged 50 years and above, black/African/Caribbean ethnic group was the least likely of all ethnic groups to be vaccinated with dose 1 of the COVID-19 vaccine. However, of those aged 70 years and above, the odds of not having dose 2 was 5.53 (95% CI 5.42 to 5.63) and 5.36 (95% CI 5.29 to 5.43) greater among Pakistani and black/African/Caribbean compared with white British ethnicity, respectively. The odds of not receiving dose 2 was 1.18 (95% CI 1.16 to 1.20) higher among individuals who lived in a care home compared with those who did not. This was the opposite to that observed for dose 1, where the odds of being unvaccinated was significantly higher among those not living in a care home (0.89 (95% CI 0.87 to 0.91)). CONCLUSIONS: We found that there are characteristics associated with low COVID-19 vaccine coverage. Inequalities, such as ethnicity are a major contributor to suboptimal coverage and tailored interventions are required to improve coverage and protect the population from SARS-CoV-2. BMJ Publishing Group 2022-03-01 /pmc/articles/PMC8889452/ /pubmed/35232787 http://dx.doi.org/10.1136/bmjopen-2021-055278 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Tessier, Elise
Rai, Yuma
Clarke, Eleanor
Lakhani, Anissa
Tsang, Camille
Makwana, Ashley
Heard, Heather
Rickeard, Tim
Lakhani, Shreya
Roy, Partho
Edelstein, Michael
Ramsay, Mary
Lopez-Bernal, Jamie
White, Joanne
Andrews, Nick
Campbell, Colin N J
Stowe, Julia
Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
title Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
title_full Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
title_fullStr Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
title_full_unstemmed Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
title_short Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level observational study
title_sort characteristics associated with covid-19 vaccine uptake among adults aged 50 years and above in england (8 december 2020–17 may 2021): a population-level observational study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889452/
https://www.ncbi.nlm.nih.gov/pubmed/35232787
http://dx.doi.org/10.1136/bmjopen-2021-055278
work_keys_str_mv AT tessierelise characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT raiyuma characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT clarkeeleanor characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT lakhanianissa characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT tsangcamille characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT makwanaashley characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT heardheather characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT rickeardtim characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT lakhanishreya characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT roypartho characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT edelsteinmichael characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT ramsaymary characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT lopezbernaljamie characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT whitejoanne characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT andrewsnick characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT campbellcolinnj characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy
AT stowejulia characteristicsassociatedwithcovid19vaccineuptakeamongadultsaged50yearsandaboveinengland8december202017may2021apopulationlevelobservationalstudy